Opioids

The Crisis Continues

Despite widespread efforts over many years, opioid overuse remains dangerously high.

~154M

Opioid prescriptions dispensed by pharmacies in 20191

80%

Percentage of heroin users who first misused prescription opioids2

75%

Opioid overdose deaths as a percentage of all drug overdose deaths in 20203

29%

Increase in drug overdose deaths in 2020 compared to 20193

Opioid Crisis

Stop Addiction Before it Starts

So far, most resources in the fight against opioid overuse have been dedicated to helping people who are already addicted. We believe prevention has been overlooked—and we’re out to change that.

Genetics:
The Missing Piece

Prescription opioids are effective for managing pain. But for some people, they bring an increased risk of addiction. Which people? Some of the answer is found in our DNA. 

solvdhealth.com

Uncovering
Hidden Risk

What if patients and healthcare providers could find out who is at increased genetic risk for opioid addiction before a prescription is written? Now they can.

Uncovering
Hidden Risk

What if patients and healthcare providers could find out who is at increased genetic risk for opioid addiction before a prescription is written? Now they can.

Designed for Decisions

AvertD™ is a clinically validated genetic test that identifies an individual’s risk for developing Opioid Use Disorder (OUD). When making prescribing decisions, AvertD offers an objective method of identifying which patients may be at increased risk of developing opioid addiction—so patients and their providers can tailor pain management plans accordingly.

1. IQVIA Xponent market research services. ©IQVIA 2020. All rights reserved.
2. Opioid Overdose Crisis. National Institute on Drug Abuse. Available online at: https://www.drugabuse.gov/drugs-abuse/opioids/opioid-overdose-crisis
3. Ahmad FB, Rossen LM, Sutton P. Provisional drug overdose death counts. National Center for Health Statistics. 2021. Accessed at https://www.cdc.gov/nchs/nvss/vsrr/drug-overdose-data.htm on July 26, 2021.

Read Our Latest Blog